Organic Letters · 2020 · 36 citations · 29 references
Natural SciencesMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular PharmacologyEnzyme InhibitionMarine Bioactive CompoundsMarine Drug DiscoveryMarine Natural ProductsMarine PharmacologyAnticancer Marine CompoundsBioactive Compounds From Marine SpongesBioactive Marine MetabolitesMarine PharmacognosyMarine Sponge MetabolitesMarine-derived Anticancer CompoundsOzonolysisSponges-derived Metabolites
A neutral-loss scanning mass method was used to explore new kynurenine-containing cycloheptapeptides, phakefustatins A–C (1–3), from the marine sponge Phakellia fusca. Their structures were elucidated by spectroscopic analysis and the advanced Marfey’s method. 1 was total synthesized via a final-stage ozonolysis strategy by the combination of solid/solution-phase synthesis. Phakefustatin A (1) was identified as a RXRα modulator to inhibit cancer cell growth, and its pharmacophores could be Kyn and guanidine groups.
29
Kiyonaga Fujii, Yoshitomo Ikai, Hisao Oka et al. · Analytical Chemistry · 1997 · 468 citations
Optimized arylomycins are a new class of Gram-negative antibiotics
Peter A. Smith, Michael F. T. Koehler, Hany S. Girgis et al. · Nature · 2018 · 357 citations
Kiyonaga Fujii, Yoshitomo Ikai, Tsuyoshi Mayumi et al. · Analytical Chemistry · 1997 · 343 citations